‘Artificial pancreas’ offers better glycaemic control than standard therapy for pregnant women with type 1 diabetes, study reveals Pregnant women treated with hybrid closed-loop therapy for type 1 diabetes mellitus spent less time at hyperglycaemic state, gained less maternal weight and had fewer hypertensive complications.…
Colchicine for cardiovascular disease: is UK clinical practice missing out? A deep dive into whether colchicine, an ancient treatment for inflammation, has a future in cardiovascular disease therapy in the UK.…
Tirzepatide more effective in blood sugar control and weight loss than semaglutide, meta-analysis finds Analysis of 22 studies revealed that tirzepatide was more effective in reducing body weight than semaglutide at all respective doses.…
E-cigarettes associated with greatest chance of smoking cessation, suggests Cochrane review The review revealed that 10–19% of people were likely to quit smoking using an e-cigarette, 12–16% using varenicline and 10–18% using cytisine.…
Filling the gap in smoking cessation therapies: a race to a smoke-free 2030 Nicotine replacement therapy is currently the only pharmacological treatment available in the UK to help tobacco smokers quit, but this is set to change.…
NICE recommends tirzepatide for type 2 diabetes in final draft guidance Following additional analyses and modelling of clinical and cost effectiveness, the National Institute for Health and Care Excellence has recommended tirzepatide for type 2 diabetes mellitus.…
NSAIDs used alongside hormonal contraception increase risk of blood clots, research suggests Researchers concluded that the absolute risk of a venous thromboembolic event remains low in concomitant use of hormonal contraception and non-steroidal anti-inflammatory drugs.…
Bupropion to be made available in the UK again from December 2023, says manufacturer Exclusive: GSK has told The Pharmaceutical Journal that bupropion tablets will be available “across the EU and Europe on or before the end of December 2023”.…
Government reverts to September start date for flu and COVID-19 vaccination programmes The vaccination programmes will now begin in September 2023, rather than October, owing to concerns over a new COVID-19 variant.…
Clopidogrel may be less effective in British South Asian patients, study results suggest The study authors concluded that non-CYP2C19-dependent antiplatelet agents would likely have a "disproportionate benefit" in the British South Asian population.…